Last Updated: November 9, 2026

CLINICAL TRIALS PROFILE FOR DISOPYRAMIDE PHOSPHATE

« Back to Dashboard

All Clinical Trials for disopyramide phosphate

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02354573 ↗	The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)	Completed	University of Aberdeen	N/A	2011-12-01	What is heart failure with normal ejection fraction? The heart contracts (pumps) and relaxes with each heartbeat. In some people with heart failure, the heart contracts normally but there is reduced relaxation of the heart. As a result, people notice a feeling of breathlessness, ankle swelling and fatigue especially on exertion. The investigators feel that patients with reduced or impaired relaxation of the heart have less heart filling time and poor energy utilisation during exercise. Therefore, the investigators are conducting a study to more thoroughly understand the disease condition by giving a drug called ivabradine to reduce the heart rate and hence to increase the heart filling time in these patients.
NCT02354573 ↗	The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)	Completed	University of Oxford	N/A	2011-12-01	What is heart failure with normal ejection fraction? The heart contracts (pumps) and relaxes with each heartbeat. In some people with heart failure, the heart contracts normally but there is reduced relaxation of the heart. As a result, people notice a feeling of breathlessness, ankle swelling and fatigue especially on exertion. The investigators feel that patients with reduced or impaired relaxation of the heart have less heart filling time and poor energy utilisation during exercise. Therefore, the investigators are conducting a study to more thoroughly understand the disease condition by giving a drug called ivabradine to reduce the heart rate and hence to increase the heart filling time in these patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for disopyramide phosphate

Condition Name

Chart
Table

Condition Name for disopyramide phosphate
Intervention	Trials
Heart Failure	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for disopyramide phosphate
Intervention	Trials
Heart Failure	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for disopyramide phosphate

Trials by Country

Map
Table

Trials by Country for disopyramide phosphate
Location	Trials
United Kingdom	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for disopyramide phosphate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for disopyramide phosphate
Clinical Trial Phase	Trials
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for disopyramide phosphate
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for disopyramide phosphate

Sponsor Name

Chart
Table

Sponsor Name for disopyramide phosphate
Sponsor	Trials
University of Aberdeen	1
University of Oxford	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for disopyramide phosphate
Sponsor	Trials
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.